Poultry

New Brochure Offers Guidelines for Aspergillosis Management in Poultry


3 August 2010

NEW BROCHURE PROVIDES GUIDELINES FOR ASPERGILLOSIS MANAGEMENT IN POULTRY

SUMMIT, New Jersey (Aug. 3, 2010) — A new brochure from Intervet/Schering-Plough Animal Health provides practical information on the control and prevention of aspergillosis, a common and aggressive fungal contamination that causes poultry producers major economic losses worldwide.

Aspergillosis is caused by the fungus Aspergillus, an omnipresent and fast-growing variety that requires only warmth, a little moisture, and plenty of organic material to thrive.  Aspergillus spores therefore find ideal breeding ground in the modern poultry production chain, particularly in hatcheries.

According to Dr. Charlie Broussard, U.S. poultry technical service director, for
Intervet/Schering-Plough Animal Health, some degree of Aspergillus contamination is almost inevitable, even on the best-managed operations: 

“The Trojan horse for the contamination can be eggs from the breeder farm, dust from the feed mill or the field, or hatchery waste,” he said.  “A single egg can shower the hatchery and ventilation system with the Aspergillus spores, which are very difficult to eliminate once they colonize.”

If aspergillosis is not effectively controlled, outbreaks can result in significant setbacks, including higher embryo mortality, early chick and growth period mortality; poor weight gain in broilers; increased treatment costs; and loss of grower confidence in chicks.

The information and case histories in the brochure show how careful control and prevention can lead to substantial savings and enhanced performance throughout the poultry production chain.

“In the case of aspergillosis, an ounce of prevention is worth considerably more than a pound of cure – especially since it’s nearly impossible to cure the problem once a contamination has occurred,” Broussard said.  “In the brochure, we show how proper sanitation, in ovo vaccination, egg transportation, biosecurity, and hatchery design contribute to preventing and controlling aspergillosis.”

Broussard noted that even when strict sanitary precautions are in place, hatcheries will still be confronted with Aspergillus.  “A strong, specific disinfectant such as Clinafarm® (imazalil) is therefore critical to controlling the fungus,” he added.  

Clinafarm is a disinfectant with specific activity against Aspergillus fungus and its spores.  In addition to safely and effectively killing the mold, Clinafarm prevents its growth by blocking the formation of ergesterol, an essential part of the fungal wall.  A spray formulation and a smoke generator are available, which may be used separately or together depending on circumstances.

For more information about Aspergillus control and a free copy of the color booklet, contact your Intervet/Schering-Plough Animal Health representative or go to www.ihc-poultry.com/clinafarm.


Clinafarm® is a registered trademark of Janssen Animal Health and is distributed in the United States by Intervet/Schering-Plough Animal Health.

About Intervet/Schering-Plough Animal Health
Intervet/Schering-Plough Animal Health, based in Boxmeer, the Netherlands, is focused on the research, development, manufacturing and marketing of animal health products. The company offers customers one of the broadest, most innovative animal health portfolios, spanning products to support performance and to prevent, treat and control disease in all major farm and companion animal species. Intervet/Schering-Plough Animal Health; subsidiaries of Merck & Co. Inc., Whitehouse Station NJ, USA. For more information, visit www.intervet.com.
 
About Merck
Today's Merck is working to help the world be well. Through our medicines, vaccines, biologic therapies, and consumer and animal products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching programs that donate and deliver our products to the people who need them. Merck. Be Well. For more information, visit www.merck.com
 
# # #